Contributor ship
Conceptualization: H. H, A.J, Data curation: A.J, F. P, Formal analysis:
F. P, Funding acquisition: A.J, H. H, Investigation: A.J, H. H, S. S. M,
Methodology: A.J, H. H, M. A, E. E, H. B, Project administration: A.J,
S. S. M, Software: A.J, F. P , Validation: H. H, M. A, E. E, H. B,
Visualization: H. H, M. A, E. E, H. B, Writing – original draft: A.J,
H. H, Writing – review & editing: A.J, H. H, N. A. G
Reference :
1. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel
coronavirus in the United States. New England Journal of
Medicine. 2020.
2. Luo S, Zhang X, Xu H. Don’t overlook digestive symptoms in patients
with 2019 novel coronavirus disease (COVID-19). Clinical
Gastroenterology and Hepatology. 2020;18(7):1636.
3. Shen K, Yang Y, Wang T, et al. Diagnosis, treatment, and prevention
of 2019 novel coronavirus infection in children: experts’ consensus
statement. World journal of pediatrics. 2020:1-9.
4. Cai J, Xu J, Lin D, et al. A Case Series of children with 2019 novel
coronavirus infection: clinical and epidemiological features.Clinical Infectious Diseases. 2020.
5. Li W, Yang Y, Liu Z-H, et al. Progression of mental health services
during the COVID-19 outbreak in China. International journal of
biological sciences. 2020;16(10):1732.
6. Bellino S, Punzo O, Rota MC, et al. COVID-19 disease severity risk
factors for pediatric patients in Italy. Pediatrics. 2020;146(4).
7. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in
China. Pediatrics. 2020;145(6).
8. Wu H, Zhu H, Yuan C, et al. Clinical and Immune Features of
Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19)
in Wuhan, China. JAMA Network Open. 2020;3(6):e2010895-e2010895.
9. Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric
patients: a systematic review. EClinicalMedicine. 2020;24:100433.
10. Stebbing J, Phelan A, Griffin I, et al. COVID-19: combining
antiviral and anti-inflammatory treatments. The Lancet Infectious
Diseases. 2020;20(4):400-402.
11. Wang Y, Zhu L-Q. Pharmaceutical care recommendations for antiviral
treatments in children with coronavirus disease 2019. World
Journal of Pediatrics. 2020:1-4.
12. Fatima U, Rizvi SSA, Fatima S, Hassan MI. Impact of
hydroxychloroquine/chloroquine in COVID-19 therapy: two sides of the
coin. Journal of Interferon & Cytokine Research.2020;40(10):469-471.
13. Cao B, Wang Y, Wen D, et al. A trial of lopinavir–ritonavir in
adults hospitalized with severe Covid-19. New England Journal of
Medicine. 2020.